Snoek FJ, Bremmer MA, Hermanns N (2015) Constructs of depression and distress in diabetes: time for an appraisal
How quickly do triglycerides improve after starting GLP-1 therapy
FeelGood's compounded GLP-1 injections and tablets are not FDA-approved
For comparison, the SURMOUNT-1 trial for tirzepatide showed an average of 20.9% weight loss at the highest dose over 72 weeks
The development of effective weight-loss therapies requires lengthy clinical trials, significant capital investment, and the capacity to manufacture at scale for global distribution
This review is focused on the inhibition of GSTs, in particular GSTP1-1, as a potential therapeutic approach for the treatment of cancer and other diseases associated with aberrant cell proliferation